{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:14:43Z","timestamp":1771326883682,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Innovation Capability Support Plan of Shaanxi Province","award":["2019TD- 034"],"award-info":[{"award-number":["2019TD- 034"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81803137"],"award-info":[{"award-number":["81803137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Free Exploration Plan of the Second Affiliated Hospital of Xi\u2019an Jiaotong University","award":["RC(XM)201807"],"award-info":[{"award-number":["RC(XM)201807"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bullous pemphigoid (BP), the most frequent blistering dermatosis in the elderly, is associated with increased mortality. The severity of BP can be assessed by detecting the anti-BP180 immunoglobulin G (IgG) concentration, but the lab test is not available in many community clinics. BP patients are usually in a hypercoagulable state with increased levels of D-dimer and fibrin degradation products (FDPs). We aimed to evaluate the use of D-dimer and FDPs in assessing BP severity. We compared the levels of plasma D-dimer, plasma FDPs, eosinophil counts, eosinophil cationic protein, and serum anti-BP180 IgG concentration between 48 typical BP patients and 33 Herpes zoster (HZ) patients (control group). Correlational analyses were conducted to determine the relationships between the lab values and common BP severity markers. The plasma D-dimer and FDP levels were higher in BP patients than in HZ controls (D-dimer: 3297\u2009\u00b1\u20092517\u00a0\u00b5g\/L vs. 569.70\u2009\u00b1\u2009412.40\u00a0\u00b5g\/L; FDP: 9.74\u2009\u00b1\u20095.88\u00a0mg\/L vs. 2.02\u2009\u00b1\u20091.69\u00a0mg\/L, respectively,<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Significant positive correlations were found between D-dimer\/FDP levels and BP severity markers (i.e. anti-BP180 IgG concentration [D-dimer:<jats:italic>r<\/jats:italic>\u2009=\u20090.3928,<jats:italic>P<\/jats:italic>\u2009=\u20090.0058; FDP:<jats:italic>r<\/jats:italic>\u2009=\u20090.4379,<jats:italic>P<\/jats:italic>\u2009=\u20090.0019] and eosinophil counts [D-dimer:<jats:italic>r<\/jats:italic>\u2009=\u20090.3625,<jats:italic>P<\/jats:italic>\u2009=\u20090.0013; FDP:<jats:italic>r<\/jats:italic>\u2009=\u20090.2880,<jats:italic>P<\/jats:italic>\u2009=\u20090.0472]) in BP patients. We also found an association between FDP and urticaria\/erythema lesions (<jats:italic>r<\/jats:italic>\u2009=\u20090.3016,<jats:italic>P<\/jats:italic>\u2009=\u20090.0372), but no other BPDAI components. In 19 BP patients with complete remission after systemic glucocorticoid treatment, D-dimer and FDP levels decreased post-therapy (D-dimer: 5559\u2009\u00b1\u20097492\u00a0\u00b5g\/L vs. 1738\u2009\u00b1\u20091478\u00a0\u00b5g\/L;<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001; FDP: 11.20\u2009\u00b1\u20095.88\u00a0mg\/L vs. 5.13\u2009\u00b1\u20093.44\u00a0mg\/L;<jats:italic>P<\/jats:italic>\u2009=\u20090.0003), whereas they did not in BP patients with treatment resistant. Plasma D-dimer and FDP are convenient markers to evaluate BP severity assistant on BPDAI and eosinophil counts. FDP is also helpful for inflammatory lesions in BP patients.<\/jats:p>","DOI":"10.1038\/s41598-021-97202-w","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T10:03:12Z","timestamp":1631008992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasma levels of D-dimer and fibrin degradation products correlate with bullous pemphigoid severity: a cross-sectional study"],"prefix":"10.1038","volume":"11","author":[{"given":"Sijia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuantao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yale","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,7]]},"reference":[{"key":"97202_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fmed.2018.00220","volume":"5","author":"K Kridin","year":"2018","unstructured":"Kridin, K. & Ludwig, R. J. The growing incidence of bullous pemphigoid: Overview and potential explanations. Front. Med. (Lausanne) 5, 220 (2018).","journal-title":"Front. Med. (Lausanne)"},{"key":"97202_CR2","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jid.2017.03.019","volume":"137","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. TWEAK\/Fn14 activation contributes to the pathogenesis of bullous pemphigoid. J. Investig. Dermatol. 137, 1512\u20131522 (2017).","journal-title":"J. Investig. Dermatol."},{"key":"97202_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.12659\/AJCR.911422","volume":"20","author":"B Ganapathineedi","year":"2019","unstructured":"Ganapathineedi, B. et al. Bullous Pemphigoid with atypical skin lesions and acute interstitial nephritis: A case report and focused literature review. Am. J. Case Rep. 20, 212\u2013218 (2019).","journal-title":"Am. J. Case Rep."},{"key":"97202_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","volume":"14","author":"E Cozzani","year":"2015","unstructured":"Cozzani, E., Gasparini, G., Burlando, M., Drago, F. & Parodi, A. Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects. Autoimmun. Rev. 14, 438\u2013445 (2015).","journal-title":"Autoimmun. Rev."},{"key":"97202_CR5","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3389\/fimmu.2017.01752","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu, Y., Li, L. & Xia, Y. BP180 is critical in the autoimmunity of bullous pemphigoid. Front. Immunol. 8, 1752 (2017).","journal-title":"Front. Immunol."},{"key":"97202_CR6","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/bjd.19611","volume":"184","author":"W Masmoudi","year":"2021","unstructured":"Masmoudi, W. et al. International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid. Br. J. Dermatol. 184, 1106\u20131112 (2021).","journal-title":"Br. J. Dermatol."},{"key":"97202_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijwd.2020.01.005","volume":"6","author":"F Farnaghi","year":"2020","unstructured":"Farnaghi, F. et al. Correlation of dermal and blood eosinophilia with bullous pemphigoid disease severity. Int. J. Womens Dermatol. 6, 171\u2013175 (2020).","journal-title":"Int. J. Womens Dermatol."},{"key":"97202_CR8","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1038\/s41598-017-04687-5","volume":"7","author":"D Giusti","year":"2017","unstructured":"Giusti, D. et al. Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome. Sci. Rep. 7, 4833 (2017).","journal-title":"Sci. Rep."},{"key":"97202_CR9","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","volume":"113","author":"SS Adam","year":"2009","unstructured":"Adam, S. S., Key, N. S. & Greenberg, C. S. D-dimer antigen: Current concepts and future prospects. Blood 113, 2878\u20132887 (2009).","journal-title":"Blood"},{"key":"97202_CR10","first-page":"1","volume-title":"Advances in Clinical Chemistry","author":"JD Olson","year":"2015","unstructured":"Olson, J. D. Chapter one-D-dimer: An overview of hemostasis and fibrinolysis, assays, and clinical applications. In Advances in Clinical Chemistry, vol. 69 (ed Makowski, G. S.) 1\u201346 (Elsevier, 2015)."},{"key":"97202_CR11","doi-asserted-by":"crossref","first-page":"A94","DOI":"10.1161\/circ.131.suppl_2.94","volume":"131","author":"M Hideki","year":"2015","unstructured":"Hideki, M. et al. Abstract 94: Diagnostic value of D-dimer and fibrinogen degradation products In Kawasaki disease. Circulation 131, A94 (2015).","journal-title":"Circulation"},{"key":"97202_CR12","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.21037\/jtd.2017.07.05","volume":"9","author":"K Akutsu","year":"2017","unstructured":"Akutsu, K. What are diagnostic implications and limitations of assessing D-dimer and fibrin degradation products levels in the management of patients with acute aortic dissection?. J. Thorac. Dis. 9, 2214\u20132216 (2017).","journal-title":"J. Thorac. Dis."},{"key":"97202_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40560-020-00466-z","volume":"8","author":"Y Yao","year":"2020","unstructured":"Yao, Y. et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J. Intensive Care 8, 49 (2020).","journal-title":"J. Intensive Care"},{"key":"97202_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/2049-6958-5-3-168","volume":"5","author":"F Coskun","year":"2010","unstructured":"Coskun, F., Yilmaz, D., Ursavas, A., Uzaslan, E. & Ege, E. Relationship between disease severity and D-dimer levels measured with two different methods in pulmonary embolism patients. Multidiscip. Respir. Med. 5, 168\u2013172 (2010).","journal-title":"Multidiscip. Respir. Med."},{"key":"97202_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2133.2008.08880.x","volume":"160","author":"AV Marzano","year":"2009","unstructured":"Marzano, A. V. et al. Activation of blood coagulation in bullous pemphigoid: Role of eosinophils, and local and systemic implications. Br. J. Dermatol. 160, 266\u2013272 (2009).","journal-title":"Br. J. Dermatol."},{"key":"97202_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/10408363.2018.1529734","volume":"55","author":"J Favresse","year":"2018","unstructured":"Favresse, J. et al. D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications. Crit. Rev. Clin. Lab. Sci. 55, 548\u2013577 (2018).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"97202_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","volume":"66","author":"DF Murrell","year":"2012","unstructured":"Murrell, D. F. et al. Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts. J. Am. Acad. Dermatol. 66, 479\u2013485 (2012).","journal-title":"J. Am. Acad. Dermatol."},{"key":"97202_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood-2006-02-004945","volume":"109","author":"C Moosbauer","year":"2007","unstructured":"Moosbauer, C. et al. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 109, 995\u20131002 (2007).","journal-title":"Blood"},{"key":"97202_CR19","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/all.13131","volume":"72","author":"E de Graauw","year":"2017","unstructured":"de Graauw, E. et al. Evidence for a role of eosinophils in blister formation in bullous pemphigoid. Allergy 72, 1105\u20131113 (2017).","journal-title":"Allergy"},{"key":"97202_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/jdv.12464","volume":"29","author":"A Tedeschi","year":"2015","unstructured":"Tedeschi, A., Marzano, A. V., Lorini, M., Balice, Y. & Cugno, M. Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid. J. Eur. Acad. Dermatol. Venereol. 29, 813\u2013817 (2015).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"97202_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","volume":"153","author":"N van Beek","year":"2017","unstructured":"van Beek, N. et al. Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity. JAMA Dermatol. 153, 30\u201338 (2017).","journal-title":"JAMA Dermatol."},{"key":"97202_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2249.2012.04674.x","volume":"171","author":"AV Marzano","year":"2013","unstructured":"Marzano, A. V., Tedeschi, A., Polloni, I., Crosti, C. & Cugno, M. Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease. Clin. Exp. Immunol. 171, 76\u201381 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"97202_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archderm.1977.01640010082015","volume":"113","author":"EW Monroe","year":"1977","unstructured":"Monroe, E. W. & Jones, H. E. Urticaria: An updated review. Arch. Dermatol. 113, 80\u201390 (1977).","journal-title":"Arch. Dermatol."},{"key":"97202_CR24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1398-9995.2010.02506.x","volume":"66","author":"T Takeda","year":"2011","unstructured":"Takeda, T. et al. Increase of coagulation potential in chronic spontaneous urticaria. Allergy 66, 428\u2013433 (2011).","journal-title":"Allergy"},{"key":"97202_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1517\/14712598.2014.875525","volume":"14","author":"AD Yalcin","year":"2014","unstructured":"Yalcin, A. D., Celik, B. & Gumuslu, S. D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment. Expert Opin. Biol. Ther. 14, 283\u2013286 (2014).","journal-title":"Expert Opin. Biol. Ther."},{"key":"97202_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.lfs.2011.03.003","volume":"88","author":"P Lu","year":"2011","unstructured":"Lu, P. et al. Pro-inflammatory effect of fibrinogen and FDP on vascular smooth muscle cells by IL-6, TNF-\u03b1 and iNOS. Life Sci. 88, 839\u2013845 (2011).","journal-title":"Life Sci."},{"key":"97202_CR27","doi-asserted-by":"publisher","first-page":"C767","DOI":"10.1152\/ajpcell.00101.2015","volume":"309","author":"M Kang","year":"2015","unstructured":"Kang, M., Vaughan, R. A. & Paton, C. M. FDP-E induces adipocyte inflammation and suppresses insulin-stimulated glucose disposal: Effect of inflammation and obesity on fibrinogen B\u03b2 mRNA. Am. J. Physiol. Cell Physiol. 309, C767\u2013C774 (2015).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"97202_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.aller.2013.06.004","volume":"42","author":"M Tavakol","year":"2014","unstructured":"Tavakol, M. et al. Interleukin-6 and tumor necrosis factor-alpha gene polymorphisms in chronic idiopathic urticaria. Allergol. Immunopathol. (Madr.) 42, 533\u2013538 (2014).","journal-title":"Allergol. Immunopathol. (Madr.)"},{"key":"97202_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1024907918790657","volume":"26","author":"M Murata","year":"2019","unstructured":"Murata, M., Hagiwara, S., Aoki, M., Nakajima, J. & Oshima, K. The significance of the levels of fibrin\/fibrinogen degradation products for predicting trauma severity. Hong Kong J. Emerg. Med. 26, 143\u2013150 (2019).","journal-title":"Hong Kong J. Emerg. Med."},{"key":"97202_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2249.2009.03989.x","volume":"158","author":"AV Marzano","year":"2009","unstructured":"Marzano, A. V. et al. Coagulation activation in autoimmune bullous diseases. Clin. Exp. Immunol. 158, 31\u201336 (2009).","journal-title":"Clin. Exp. Immunol."},{"key":"97202_CR31","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.4049\/jimmunol.153.6.2664","volume":"153","author":"M Minnicozzi","year":"1994","unstructured":"Minnicozzi, M., Dur\u00e1n, W. N., Gleich, G. J. & Egan, R. W. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J. Immunol. 153, 2664\u20132670 (1994).","journal-title":"J. Immunol."},{"key":"97202_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.autrev.2013.08.001","volume":"13","author":"M Cugno","year":"2014","unstructured":"Cugno, M., Gualtierotti, R., Tedeschi, A. & Meroni, P. L. Autoantibodies to coagulation factors: From pathophysiology to diagnosis and therapy. Autoimmun. Rev. 13, 40\u201348 (2014).","journal-title":"Autoimmun. Rev."},{"key":"97202_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00062752-199909000-00009","volume":"6","author":"BG Macik","year":"1999","unstructured":"Macik, B. G. & Crow, P. Acquired autoantibodies to coagulation factors. Curr. Opin. Hematol. 6, 323\u2013328 (1999).","journal-title":"Curr. Opin. Hematol."},{"key":"97202_CR34","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1128\/IAI.01104-13","volume":"82","author":"KR Short","year":"2014","unstructured":"Short, K. R. et al. Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media. Infect. Immun. 82, 364\u2013370 (2014).","journal-title":"Infect. Immun."},{"key":"97202_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3389\/fimmu.2019.00701","volume":"10","author":"D Giusti","year":"2019","unstructured":"Giusti, D. et al. NET formation in bullous pemphigoid patients with relapse is modulated by IL-17 and IL-23 interplay. Front. Immunol. 10, 701 (2019).","journal-title":"Front. Immunol."},{"key":"97202_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.7308","author":"A Blasco","year":"2020","unstructured":"Blasco, A. et al. Assessment of neutrophil extracellular traps in coronary thrombus of a case series of patients with COVID-19 and myocardial infarction. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.7308 (2020).","journal-title":"JAMA Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97202-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97202-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97202-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T19:30:45Z","timestamp":1673206245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97202-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["97202"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-97202-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,7]]},"assertion":[{"value":"14 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17746"}}